National Institute of Allergy and Infectious Diseases
Link to NIAID Home Page Link to NIAID Home Page Link to NIH Home Page
NIAID Home Health & Science Research Funding Research News & Events Labs at NIAID About NIAID

Genital Warts
 Research
 Understanding
  Cause
  Transmission
  Symptoms
  Diagnosis
  Treatment
  Prevention
  Complications


Human Papillomavirus and Genital Warts

Prevention

The best way to prevent getting an HPV infection is to avoid direct contact with the virus, which is transmitted by skin-to-skin contact.  If you or your sexual partner has warts that can be seen in the genital area, you should avoid any skin-to-skin and sexual contact until the warts are treated.

Recently, the Food and and Drug Administration (FDA) approved a vaccine called Gardasil. Gardasil is highly effective in preventing persistent infection with HPV types 16 and 18, two "high-risk" HPVs that cause most (70 percent) of cervical cancers, and types 6 and 11, which cause virtually all (90 percent) of genital warts.

Gardasil has not been proven to provide complete protection against persistent infection with other HPV types, some of which also can cause cervical canter. Therefore, about 30 percent of cervical cancers and 10 percent of genital warts will not be prevented by the current vaccine. In addition, Gardasil does not prevent other STIs, nor does it treat HPV infection or cervical cancer.

The CDC Advisory Committee on Immunization Practices (ACIP) has federal HPV vaccine recommendations. In addition, the National Cancer Institute and CDC have more information on the HPV vaccine.

Historically, research studies have not confirmed that male latex condoms prevent transmission of HPV. Recent studies, however, demonstrate that consistent condom use by male partners suggests strong protection against low- and high-risk types of HPV infection in women.

Unfortunately, many people who don't have symptoms don't know that they can spread the virus to an uninfected partner.

back to top


Volunteer for Clinical Studies
Volunteer for NIAID-funded clinical studies related to human papillomavirus and genital warts on ClinicalTrials.gov.

See Also

  • Sexually Transmitted Infections News Releases
  • Sexually Transmitted Infections
  • Related Links

    View a list of links for more information about human papillomavirus and genital warts.

    E-mail Icon E-mail this page
    Print Icon Print this page

    Volunteer for Clinical Studies
    Volunteer for NIAID-funded clinical studies related to human papillomavirus and genital warts on ClinicalTrials.gov.

    See Also

  • Sexually Transmitted Infections News Releases
  • Sexually Transmitted Infections
  • Related Links

    View a list of links for more information about human papillomavirus and genital warts.